Credelio Plus
Commercial- Indications
- Pet parasitic diseases
Company intelligence / Profile preview
Elanco Animal Health
Indianapolis, Indiana, United Stateselanco.com ↗
- Ownership
- Public · ELAN
- Employees
- ~6500
- Development stage
- Commercial
01
Overview
Elanco is launching one of its biggest pipelines in its 70-year history, with six potential blockbuster treatments expected by 2025[3]
- Therapeutic areas
- OtherEndocrinology
- Modalities
- Medicinesvaccinesparasiticides
- Industry
- Veterinary
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Purdue UniversityApplied Research InstituteAgriNovusBiomEdit[5]
04
Financials
- Market cap
- $11.4B
- Total revenue
- $1.4B
- Enterprise value
- $14.8B
Beyond the preview
Go deeper on Elanco Animal Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Elanco Animal Health.